Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Oncotarget|March 24, 2015
Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinomaMaria Inés Molejon, Juan Ignacio Tellechea, Celine Loncle, et al.The American Journal of Pathology|March 14, 2015
Transcriptomic analysis predicts survival and sensitivity to anticancer drugs of patients with a pancreatic adenocarcinomaPauline Duconseil, Marine Gilabert, Odile Gayet, et al.Oncotarget|December 8, 2014
A subgroup of pancreatic adenocarcinoma is sensitive to the 5-aza-dC DNA methyltransferase inhibitorOdile Gayet, Celine Loncle, Pauline Duconseil, et al.Oncotarget|July 28, 2016
A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPTMarine Barraud, Jonathan Garnier, Celine Loncle, et al.Ebiomedicine|July 7, 2020
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancerRémy Nicolle, Yuna Blum, Pauline Duconseil, et al.Nature Communications|May 19, 2018
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypesGwen Lomberk, Yuna Blum, Rémy Nicolle, et al.Cell Reports|November 30, 2017
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived XenograftsRémy Nicolle, Yuna Blum, Laetitia Marisa, et al.Pageof 2